ResMed Inc. (RMD)
After hours:
- Simply Wall St.
ResMed's (NYSE:RMD) five-year earnings growth trails the 8.2% YoY shareholder returns
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...
- GlobeNewswire
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
Published in the Journal of the American Medical Association Network Open, study estimates global COPD burden from 2020 through 2050 Study projects disproportionate growth in COPD among women and low-middle income regions SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open,
- Zacks
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
